Nutraceutix Acquires Rights to New Delivery Patent

Nutraceutix Acquires Rights to New Delivery Patent

REDMOND, Wash.--Nutraceutix Inc., based here, has acquired the exclusiverights to a new drug delivery patent (#6,090,411) from Temple University Schoolof Pharmacy. "This new patent provides Nutraceutix with a cleartechnological advantage over first generation, controlled deliverysystems," said to David Howard, president and chief executive officer ofNutraceutix. The company currently holds patents on several ingredients anddelivery technologies. For more information, visit www.nutraceutix.com.